FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

35632911000001101: Buprenorphine 8mg / Naloxone 2mg sublingual tablets sugar free (Alliance Healthcare (Distribution) Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 08-Aug 2018. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
109413101000001116 Buprenorphine 8mg / Naloxone 2mg sublingual tablets sugar free (Alliance Healthcare (Distribution) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
109413201000001111 Buprenorphine 8mg / Naloxone 2mg sublingual tablets sugar free (Alliance Healthcare (Distribution) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Buprenorphine 8mg / Naloxone 2mg sublingual tablets sugar free (Alliance Healthcare (Distribution) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 3 (CD No Register) true Inferred relationship Existential restriction modifier
Buprenorphine 8mg / Naloxone 2mg sublingual tablets sugar free (Alliance Healthcare (Distribution) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Buprenorphine 8mg / Naloxone 2mg sublingual tablets sugar free (Alliance Healthcare (Distribution) Ltd) Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Buprenorphine 8mg / Naloxone 2mg sublingual tablets sugar free (Alliance Healthcare (Distribution) Ltd) Has specific active ingredient Naloxone hydrochloride dihydrate true Inferred relationship Existential restriction modifier
Buprenorphine 8mg / Naloxone 2mg sublingual tablets sugar free (Alliance Healthcare (Distribution) Ltd) Is a Buprenorphine 8mg / Naloxone 2mg sublingual tablets sugar free true Inferred relationship Existential restriction modifier
Buprenorphine 8mg / Naloxone 2mg sublingual tablets sugar free (Alliance Healthcare (Distribution) Ltd) Has active ingredient Naloxone true Inferred relationship Existential restriction modifier
Buprenorphine 8mg / Naloxone 2mg sublingual tablets sugar free (Alliance Healthcare (Distribution) Ltd) Has active ingredient Buprenorphine true Inferred relationship Existential restriction modifier
Buprenorphine 8mg / Naloxone 2mg sublingual tablets sugar free (Alliance Healthcare (Distribution) Ltd) Has manufactured dose form Conventional release sublingual tablet true Inferred relationship Existential restriction modifier
Buprenorphine 8mg / Naloxone 2mg sublingual tablets sugar free (Alliance Healthcare (Distribution) Ltd) Has basis of strength substance Naloxone true Inferred relationship Existential restriction modifier
Buprenorphine 8mg / Naloxone 2mg sublingual tablets sugar free (Alliance Healthcare (Distribution) Ltd) Has basis of strength substance Buprenorphine true Inferred relationship Existential restriction modifier
Buprenorphine 8mg / Naloxone 2mg sublingual tablets sugar free (Alliance Healthcare (Distribution) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Buprenorphine 8mg / Naloxone 2mg sublingual tablets sugar free (Alliance Healthcare (Distribution) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Buprenorphine 8mg / Naloxone 2mg sublingual tablets sugar free (Alliance Healthcare (Distribution) Ltd) Has specific active ingredient Buprenorphine hydrochloride true Inferred relationship Existential restriction modifier
Buprenorphine 8mg / Naloxone 2mg sublingual tablets sugar free (Alliance Healthcare (Distribution) Ltd) Has specific active ingredient Naloxone hydrochloride false Inferred relationship Existential restriction modifier
Buprenorphine 8mg / Naloxone 2mg sublingual tablets sugar free (Alliance Healthcare (Distribution) Ltd) Has dispensed dose form Conventional release sublingual tablet true Inferred relationship Existential restriction modifier
Buprenorphine 8mg / Naloxone 2mg sublingual tablets sugar free (Alliance Healthcare (Distribution) Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Naloxone false Inferred relationship Existential restriction modifier
Buprenorphine 8mg / Naloxone 2mg sublingual tablets sugar free (Alliance Healthcare (Distribution) Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Buprenorphine true Inferred relationship Existential restriction modifier
Buprenorphine 8mg / Naloxone 2mg sublingual tablets sugar free (Alliance Healthcare (Distribution) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Buprenorphine 8mg / Naloxone 2mg sublingual tablets sugar free (Alliance Healthcare (Distribution) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Buprenorphine 8mg / Naloxone 2mg sublingual tablets sugar free (Alliance Healthcare (Distribution) Ltd) Has specific active ingredient Naloxone hydrochloride dihydrate false Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Buprenorphine 8mg / Naloxone 2mg sublingual tablets sugar free (Alliance Healthcare (Distribution) Ltd) 28 tablet Has AMP True Buprenorphine 8mg / Naloxone 2mg sublingual tablets sugar free (Alliance Healthcare (Distribution) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start